Re-expression of DLC1 upon DZNep treatment was also observed in different cancer cell lines including the nasopharyngeal carcinoma cell line CNE2, colorectal carcinoma cell line HCT116 and cervical adenocarcinoma cell line HeLa (Figure 2F). The gene discussed is DLC1; the disease is nasopharyngeal carcinoma.